The Oncology Institute, Inc. TOI Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from The Oncology Institute, Inc.’s reported figures.
Based on trailing twelve months.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s operating margin?
- The Oncology Institute, Inc. (TOI) reported operating margin of -6% in Q1 2026.
- How has The Oncology Institute, Inc.'s operating margin changed year-over-year?
- The Oncology Institute, Inc.'s operating margin increased by 53.6% year-over-year, from -12.9% to -6%.
- What is the long-term trend for The Oncology Institute, Inc.'s operating margin?
- Over 5 years (2020 to 2025), The Oncology Institute, Inc.'s operating margin has grown at a 10.4% compound annual growth rate (CAGR), from -4.4% to -7.2%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.